company background image
OABI logo

OmniAb NasdaqGM:OABI Stock Report

Last Price

US$3.83

Market Cap

US$473.2m

7D

-1.8%

1Y

-19.4%

Updated

04 Dec, 2024

Data

Company Financials +

OABI Stock Overview

A biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. More details

OABI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

OmniAb, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OmniAb
Historical stock prices
Current Share PriceUS$3.83
52 Week HighUS$6.72
52 Week LowUS$3.56
Beta0.38
11 Month Change-11.55%
3 Month Change-6.81%
1 Year Change-19.37%
33 Year Changen/a
5 Year Changen/a
Change since IPO-57.16%

Recent News & Updates

Recent updates

OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 15
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates

Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

Sep 14
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

Jul 15
Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 12
The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Mar 26
Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

Feb 28
Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Jan 15
OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Nov 11
Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

Aug 13
Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

May 14
OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

Shareholder Returns

OABIUS Life SciencesUS Market
7D-1.8%0.3%1.4%
1Y-19.4%4.5%33.6%

Return vs Industry: OABI underperformed the US Life Sciences industry which returned 5.5% over the past year.

Return vs Market: OABI underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is OABI's price volatile compared to industry and market?
OABI volatility
OABI Average Weekly Movement6.6%
Life Sciences Industry Average Movement9.0%
Market Average Movement6.3%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

Stable Share Price: OABI has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: OABI's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012106Matt Foehrwww.omniab.com

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company’s technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners’ drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates.

OmniAb, Inc. Fundamentals Summary

How do OmniAb's earnings and revenue compare to its market cap?
OABI fundamental statistics
Market capUS$473.16m
Earnings (TTM)-US$63.02m
Revenue (TTM)US$20.41m

22.7x

P/S Ratio

-7.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OABI income statement (TTM)
RevenueUS$20.41m
Cost of RevenueUS$0
Gross ProfitUS$20.41m
Other ExpensesUS$83.43m
Earnings-US$63.02m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.52
Gross Margin100.00%
Net Profit Margin-308.78%
Debt/Equity Ratio0%

How did OABI perform over the long term?

See historical performance and comparison